This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Macular Hole or Surgery
and you are
between 50 and 80
years old
The phase for this study is not defined.
Show me locations

The purpose

To compare the morphologic and functional outcomes of internal limiting membrane peeling-reposition versus peeling in idiopathic macular holes

Provided treatments

  • Procedure: peeling-reposition
  • Procedure: peeling
  • Drug: Brilliant Blue G
  • Other: postoperative posture
  • Device: Constellation 23-gauge vitrectomy system

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03020459. The sponsor of the trial is Xinhua Hospital, Shanghai Jiao Tong University School of Medicine and it is looking for 30 volunteers for the current phase.
Official trial title:
Comparing the Surgical Outcomes of Internal Limiting Membrane Peeling-reposition Versus Peeling in Idiopathic Macular Holes: A Randomized Controlled Trial